| Adult Acute Basophilic Leukemia studied in …STUDIED_INderived10 of 20show all (up to 200) |
|---|
| → studied in | NCT02071901Phase 2 · completed Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ONTOLOGY_EXACT · 20 trials mapped (1 active) | — | — | Adult Acute Basophilic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01627041Phase 2 · active not recruiting Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 20 trials mapped (1 active) | — | — | Adult Acute Basophilic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01550185Phase 1 · terminated Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 20 trials mapped (1 active) | — | — | Adult Acute Basophilic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352365Phase 2 · completed Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 20 trials mapped (1 active) | — | — | Adult Acute Basophilic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260714Phase 1 · terminated Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 20 trials mapped (1 active) | — | — | Adult Acute Basophilic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00407966Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 20 trials mapped (1 active) | — | — | Adult Acute Basophilic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217646Phase 1 · completed Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia · condition mapped ONTOLOGY_EXACT · 20 trials mapped (1 active) | — | — | Adult Acute Basophilic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00383474Phase 1 · completed Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase · condition mapped ONTOLOGY_EXACT · 20 trials mapped (1 active) | — | — | Adult Acute Basophilic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096122Phase 1/Phase 2 · completed Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 20 trials mapped (1 active) | — | — | Adult Acute Basophilic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098423Phase 1 · completed Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 20 trials mapped (1 active) | — | — | Adult Acute Basophilic Leukemia | 1 | Observed | clinicaltrials | graph → |